AstraZeneca's Lynparza Slows Spread of Rare Pancreatic Cancer

(Bloomberg) -- AstraZeneca Plc’s Lynparza, a treatment for breast and ovarian cancers triggered by flaws in a gene called BRCA, appears to be effective against uncommon pancreatic cancers tied to t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.